Applied Microbiology and Biotechnology

, Volume 97, Issue 14, pp 6427–6437 | Cite as

Biotransformation and recovery of the isoflavones genistein and daidzein from industrial antibiotic fermentations

  • J. Mark Weber
  • Andrew R. Reeves
  • Ramya Seshadri
  • William H. Cernota
  • Melissa C. Gonzalez
  • Danielle L. Gray
  • Roy K. Wesley
Applied microbial and cell physiology

Abstract

The objective of this study was to follow the metabolic fate of isoflavone glucosides from the soybean meal in a model industrial fermentation to determine if commercially useful isoflavones could be harvested as coproducts from the spent broth at the end of the fermentation. The isoflavone aglycones, genistein, and daidzein together make up 0.1–0.2 % of the soybean meal by weight but serve no known function in the manufacturing process. After feeding genistein to washed cells of the erythromycin-producing organism, Saccharopolyspora erythraea, the first biotransformation product (Gbp1) was determined by X-ray crystallography to be genistein-7-O-α-rhamnoside (rhamnosylgenistein). Subsequent feeding of rhamnosylgenistein to growing cells of Saccharopolyspora erythraea led to the production of a second biotransformation product, Gbp2. Chromatographic evidence suggested that Gbp2 accumulated in the spent broth of the erythromycin fermentation. When the spent broth was hydrolyzed with acid or industrial enzyme preparations, the isoflavone biotransformation products were returned back to their parental forms, genistein and daidzein, which were then recovered as coproducts. Desirable features of this method are that it does not require modification of the erythromycin manufacturing process or genetic engineering of the producing organism to be put into practice. A preliminary investigation of five additional antibiotic fermentations of industrial importance also found isoflavone coproduct potential.

Keywords

Isoflavones Genistein Daidzein Coproduct Soybean Fermentation Saccharopolyspora erythraea 7-O-rhamnosylgenistein 

Notes

Acknowledgments

We acknowledge the Small Business Innovation Research program and the National Institutes of Health for grants R43 CA93165 and R44 CA93165 from the National Center for Complementary and Alternative Medicine. We acknowledge Igor Brikun, Andrey Fedashtchin, Noelle Kwan, Ben Leach, Cheryl Iverson, and John Aikens for the helpful discussions.

Supplementary material

253_2013_4839_MOESM1_ESM.doc (76 kb)
ESM 1 (DOC 76 kb)

References

  1. Bérdy J (2005) Bioactive microbial metabolites, a personal view. J Antibiot 58:1–26CrossRefGoogle Scholar
  2. Chimura H, Sawa T, Kumada Y, Naganawa H, Matsuzaki M, Takita T, Hamada M, Takeuchi T, Umezawa H (1975) New isoflavones, inhibiting catechol-O-methyltransferase, produced by Streptomyces. J Antibiot 28:619–626CrossRefGoogle Scholar
  3. Cortes J, Velasco J, Foster G, Blackaby AP, Rudd BA, Wilkinson B (2002) Identification and cloning of a type III polyketide synthase required for diffusible pigment biosynthesis in Saccharopolyspora erythraea. Mol Microbiol 44:1213–1224CrossRefGoogle Scholar
  4. Dijsselbloem N, Vanden Berghe W, De Naeyer A, Haegeman G (2004) Soy isoflavone phyto-pharmaceuticals in interleukin-6 affections. Multi-purpose nutraceuticals at the crossroad of hormone replacement, anti-cancer and anti-inflammatory therapy. Biochem Pharmacol 68:1171–1185CrossRefGoogle Scholar
  5. Fidler DJ, George B, Quarles CL, Kidd MT (2003a) Broiler performance and carcass traits as affected by dietary liquid Saccharopolyspora solubles concentrate. J Appl Poult Res 12:153–159Google Scholar
  6. Fidler DJ, Lampel JS, Weyant DB (September 2003b) Concentrated spent fermentation beer or Saccharopolyspora erythraea activated by an enzyme mixture as a nutritional feed supplement. U.S. patent 6,616,953Google Scholar
  7. Hessler PE, Larsen PE, Constantinou AI, Schram KH, Weber JM (1997) Isolation of isoflavones from soy-based fermentations of the erythromycin-producing bacterium Saccharopolyspora erythraea. Appl Microbiol Biotechnol 47:398–404CrossRefGoogle Scholar
  8. Hosny M, Rosazza J (1999) Microbial hydroxylation and methylation of genistein by streptomycetes. J Nat Prod 62:1609–1612CrossRefGoogle Scholar
  9. Kidd MT, Fidler DJ, Koch KB, George B, Quarles CL (2003) Dietary addition of liquid Saccharopolyspora solubles concentrate positively affects pellet mill throughput and broiler performance. J Appl Poult Res 12:145–152Google Scholar
  10. Komiyama K, Funayama S, Anraku Y, Mita A, Takahashi Y, Omura S, Shimasaki H (1989) Isolation of isoflavonoids possessing antioxidant activity from the fermentation broth of Streptomyces sp. J Antibiot 42:1344–1349CrossRefGoogle Scholar
  11. Maatooq GT, Rosazza JP (2005) Metabolism of daidzein by Nocaradia species NRRL 5646 and Mortierella isabellina ATCC 38063. Phytochemistry 66:1007–1011CrossRefGoogle Scholar
  12. Minas W (2005) Production of erythromycin with Saccharopolyspora erythraea. In: Barredo JL (ed) Methods in biotechnology, Vol. 18: microbial processes and products. Humana, Totowa, pp 65–89CrossRefGoogle Scholar
  13. Murphy PA, Hendrich S (2002) Phytoestrogens in foods. Adv Food Nutr Res 44:195–246CrossRefGoogle Scholar
  14. Queener SW, Lively DH (1986) In: Demain AL, Soloman NA (eds) Manual of industrial microbiology and biotechnology. American Society for Microbiology, Washington DC, pp 155–169Google Scholar
  15. Quirós LM, Aguirrezabalaga I, Olano C, Méndez C, Salas JA (1998) Two glycosyltransferases and a glycosidase are involved in oleandomycin modification during its biosynthesis by Streptomyces antibioticus. Mol Microbiol 28:1177–1185CrossRefGoogle Scholar
  16. Reeves AR, Cernota WH, Brikun IA, Wesley RK, Weber JM (2004) Engineering precursor flow for increased erythromycin production in Aeromicrobium erythreum. Metab Eng 6:300–312CrossRefGoogle Scholar
  17. Reeves AR, Brikun IA, Cernota WH, Leach BI, Gonzalez MC, Weber JM (2006) Effects of methylmalonyl-CoA mutase gene knockouts on erythromycin production in carbohydrate-based and oil-based fermentations of Saccharopolyspora erythraea. J Ind Microbiol Biotechnol 33:600–609CrossRefGoogle Scholar
  18. Reeves AR, Weber JM, Brikun IA (2007) Methods of increasing production of secondary metabolites by manipulating metabolic pathways that include methylmalonyl-CoA. U S Pat Appl 20070122885Google Scholar
  19. Reeves AR, Seshadri R, Brikun IA, Cernota WH, Gonzalez MC, Weber JM (2008) Knockout of the erythromycin biosynthetic cluster gene, eryBI, blocks isoflavone glucoside bioconversion during erythromycin fermentations in Aeromicrobium erythreum but not in Saccharopolyspora erythraea. Appl Environ Microbiol 74:7383–7390CrossRefGoogle Scholar
  20. Seo J, Kang S, Kim M, Han J, Hur H-G (2011) Flavonoids biotransformation by bacterial non-heme dioxygenases, biphenyl and naphthalene dioxygenase. Appl Microbiol Biotechnol 91:219–228CrossRefGoogle Scholar
  21. Sheldrick GM (2008a) SADABS; Department of Structural Chemistry. University of Göttingen, Göttingen, GermanyGoogle Scholar
  22. Sheldrick GM (2008b) Acta Crystallogr Sect A: Found Crystallogr 64:112–122CrossRefGoogle Scholar
  23. Swanson M, Stoll M, Schapaugh W, Takemoto L (2004) Isoflavone content of Kansas soybeans. Am J Undergr Res 2:27–32Google Scholar
  24. Virk-Baker MK, Nagy TR, Barnes S (2010) Role of phytoestrogens in cancer therapy. Planta Med 76:1132–1142, Epub 2010 Jul 1CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • J. Mark Weber
    • 1
  • Andrew R. Reeves
    • 1
    • 3
  • Ramya Seshadri
    • 1
    • 4
  • William H. Cernota
    • 1
  • Melissa C. Gonzalez
    • 1
    • 5
  • Danielle L. Gray
    • 2
  • Roy K. Wesley
    • 1
  1. 1.Fermalogic, IncChicagoUSA
  2. 2.School of Chemical SciencesUniversity of IllinoisUrbanaUSA
  3. 3.Coskata, IncWarrenvilleUSA
  4. 4.Abbott MolecularDes PlainesUSA
  5. 5.Department of Cellular and Molecular BiologyNorthwestern UniversityChicagoUSA

Personalised recommendations